26.03
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
What margin trends mean for ClearPoint Neuro Inc. stockTrade Volume Summary & Short-Term High Return Ideas - newser.com
Clearpoint Neuro Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
What the charts say about ClearPoint Neuro Inc. todayVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Will earnings trigger a reversal in ClearPoint Neuro Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
What momentum indicators show for ClearPoint Neuro Inc. stockMarket Trend Report & Verified Stock Trade Ideas - newser.com
Tools to assess ClearPoint Neuro Inc.’s risk profileDip Buying & Short-Term Trading Alerts - newser.com
Can ClearPoint Neuro Inc. stock hit record highs againPortfolio Return Report & Entry and Exit Point Strategies - newser.com
Using economic indicators to assess ClearPoint Neuro Inc. potentialLong Setup & Stepwise Entry and Exit Trade Signals - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
ClearPoint Neuro (CLPT): Assessing Valuation Ahead of Upcoming Industry Conference Reveal - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85 - Markets Mojo
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring Growth in the Medical Devices Sector - DirectorsTalk Interviews
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com Nigeria
ClearPoint Neuro reports positive results from brain tumor laser therapy study By Investing.com - Investing.com South Africa
ClearPoint Neuro Reports Phase I-II Study: Improved Survival | CLPT Stock News - Stock Titan
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Nigeria
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Hits New 52-Week HighHere's What Happened - MarketBeat
ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 5.9%Still a Buy? - MarketBeat
ClearPoint Neuro developing robotic navigation system for brain surgeries - Investing.com
ClearPoint Neuro developing robotic navigation system for brain surgeries By Investing.com - Investing.com Australia
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):